Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Firefly Neuroscience (AIFF) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Firefly Neuroscience (AIFF) over the last 15 years, with Q3 2025 value amounting to $2.8 million.

  • Firefly Neuroscience's Operating Expenses fell 3485.24% to $2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.3 million, marking a year-over-year increase of 2479.72%. This contributed to the annual value of $10.2 million for FY2024, which is 18417.23% up from last year.
  • Latest data reveals that Firefly Neuroscience reported Operating Expenses of $2.8 million as of Q3 2025, which was down 3485.24% from $1.9 million recorded in Q2 2025.
  • In the past 5 years, Firefly Neuroscience's Operating Expenses ranged from a high of $4.3 million in Q3 2024 and a low of $670000.0 during Q3 2023
  • Over the past 5 years, Firefly Neuroscience's median Operating Expenses value was $1.7 million (recorded in 2023), while the average stood at $2.0 million.
  • In the last 5 years, Firefly Neuroscience's Operating Expenses crashed by 6487.24% in 2023 and then skyrocketed by 54194.03% in 2024.
  • Firefly Neuroscience's Operating Expenses (Quarter) stood at $4.3 million in 2021, then tumbled by 64.12% to $1.5 million in 2022, then rose by 3.23% to $1.6 million in 2023, then surged by 119.99% to $3.5 million in 2024, then decreased by 19.69% to $2.8 million in 2025.
  • Its last three reported values are $2.8 million in Q3 2025, $1.9 million for Q2 2025, and $2.1 million during Q1 2025.